Tuesday, April 16, 2024

Tuesday, April 16, 2024

Organization Directory

Refine Your Search Non-Profit Associations R

Type:

Filter by Org Category:

Filter By Name:


Trending

  1. 1 ASTELLAS PHARMA INC.: FDA Accepts for Priority Review the New Drug Application for mirabegron for Oral Suspension and Supplemental New Drug Application for Myrbetriq® (mirabegron) Tablets in Pediatric Patients
  2. 2 LOCATE BIO: CognitOss Granted FDA Breakthrough Device Designation
FDA Reporter